Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model
نویسندگان
چکیده
s/ Presentations Schultz V, Paap F, Scheidt U, Brück W, Junker A. Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model. Presented as a poster at the 58th Annual meeting of the German Society for Neuropathology and Neuroanatomy (DGNN), 11th-14th September 2012, in Göttingen, Germany Schultz V, Paap F, Scheidt U, Junker A. Disrupted CD47 signaling in MS lesions leads to failed remyelination. Presented as a talk at the 5th NEUROWIND e.V. meeting, 25th-27th October 2013, in Berlin, Germany Schultz V, Paap F, Scheidt U, Stadelmann C, Brück W, Junker A. Axonal degeneration and protection during early remyelination in multiple sclerosis and an animal model. Presented as a poster at the 12th International Congress of Neuroimmunology (ISNI), 09th-13th November 2014, in Mainz, Germany
منابع مشابه
P 46: The Role of Kv7-Channels in the Pathophysiology of Multiple Sclerosis
Multiple sclerosis is an autoimmune CNS-disease characterized by inflammatory neurodegenerative events occurring with de- and remyelination. Recent evidence show that demyelinated neurons are less excitable than myelinated ones while at early stages of remyelination these neurons seem to be hyperexcitable. The latter is a transitory condition that, very likely, leads to impaired neuronal networ...
متن کاملImaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
Multiple sclerosis (MS) is a central nervous system (CNS) disease characterized by chronic neuroinflammation, demyelination, and axonal damage. Infiltration of activated lymphocytes and myeloid cells are thought to be primarily responsible for white matter damage and axonopathy. Over time, this neurologic damage manifests clinically as debilitating motor and cognitive symptoms. Existing MS ther...
متن کاملAcutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination
Remyelination is in the center of new therapies for the treatment of multiple sclerosis to resolve and improve disease symptoms and protect axons from further damage. Although remyelination is considered beneficial in the long term, it is not known, whether this is also the case early in lesion formation. Additionally, the precise timing of acute axonal damage and remyelination has not been ass...
متن کاملPromoting remyelination in multiple sclerosis: current drugs and future prospects.
Myelin destruction due to inflammatory oligodendrocyte cell damage or death in conjunction with axonal degeneration are among the major histopathological hallmarks of multiple sclerosis (MS). The majority of available immunomodulatory medications for MS are approved for relapsing-remitting (RR) MS, for which they reduce relapse rate, MRI measures of inflammation, and the accumulation of disabil...
متن کاملMechanisms of remyelination: recent insight from experimental models.
Oligodendrocytes and myelin play essential roles in the vertebrate central nervous system. Demyelination disrupts saltatory nerve conduction, leading to axonal degeneration and neurological disabilities. Remyelination is a regenerative process that replaces lost myelin. However, remyelination is disrupted in demyelinating diseases such as multiple sclerosis, at least partially, due to the failu...
متن کامل